Lotiglipron
Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
Pfizer · Phase 2 · Terminated · Enrollment 902
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.